헬스케어 수탁 연구 아웃소싱(CRO) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Healthcare Contract Research Outsourcing Market size is expected to reach USD 115.41 Billion in 2034 from USD 61.37 Billion (2025) growing at a CAGR of 7.27% during 2026-2034.

The healthcare contract research outsourcing (CRO) market is poised for substantial growth, driven by the increasing demand for efficient and cost-effective solutions in clinical research and drug development. As pharmaceutical and biotechnology companies seek to streamline their operations and reduce time-to-market for new therapies, the reliance on CROs for specialized expertise and resources is becoming more prevalent. The market is witnessing a surge in demand for a wide range of services, including clinical trial management, data analysis, and regulatory support, as organizations aim to enhance their research capabilities.

Innovations in technology and data management are shaping the future of the healthcare CRO market. The integration of advanced analytics, artificial intelligence, and machine learning is enabling CROs to optimize clinical trial designs, improve patient recruitment, and enhance data integrity. Additionally, the rise of decentralized clinical trials and remote monitoring solutions is transforming the way research is conducted, allowing for greater flexibility and efficiency in data collection. As regulatory environments evolve, CROs are increasingly focusing on compliance and quality assurance to meet the stringent requirements of health authorities.

Moreover, the healthcare CRO market will benefit from increased collaboration between CROs, pharmaceutical companies, and academic institutions to foster innovation and improve research outcomes. As the landscape evolves, the focus will shift towards developing strategic partnerships that leverage the strengths of each stakeholder, enhancing the overall efficiency of the drug development process. The emphasis on patient-centric approaches and real-world evidence will also play a crucial role in shaping the future of healthcare CRO services, ensuring that clinical research aligns with the needs and preferences of patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Clinical Trial Service
• Regulatory Service
• Clinical Data Management & Biometrics
• Medical Writing
• Pharmacovigilance
• Site Management Protocol
• Others

By Therapeutic Area

• Oncology / Hematology
• CNs
• CV/Metabolic
• Respiratory
• Infectious Diseases
• Immunology
• Rare Diseases
• Medical Devices
• Others

By End-user

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Academic Institutes & Government Organizations

COMPANIES PROFILED

• Syneos Health, PAREXEL International, ICON plc, PRA Health Sciences Inc, Charles River, Laboratory Corporation of America Holdings Covance, IQVIA, Medpace, Pharmaceutical Product Development LLC

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Clinical Trial Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Regulatory Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clinical Data Management & Biometrics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Site Management Protocol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapeutic Area
• 5.2. Oncology / Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. CNs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. CV/Metabolic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Rare Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Institutes & Government Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service
  • 7.2.2 By Therapeutic Area
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service
  • 7.3.2 By Therapeutic Area
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service
  • 7.4.2 By Therapeutic Area
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service
  • 7.5.2 By Therapeutic Area
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service
  • 7.6.2 By Therapeutic Area
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Syneos Health
  • 9.2.2 PAREXEL International
  • 9.2.3 ICON Plc
  • 9.2.4 PRA Health Sciences Inc
  • 9.2.5 Charles River
  • 9.2.6 Laboratory Corporation Of America Holdings (Covance)
  • 9.2.7 IQVIA
  • 9.2.8 Medpace
  • 9.2.9 Pharmaceutical Product Development LLC